2019
DOI: 10.1016/j.gie.2018.08.047
|View full text |Cite
|
Sign up to set email alerts
|

Single-stage EUS-guided choledochoduodenostomy using a lumen-apposing metal stent for malignant distal biliary obstruction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
111
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 140 publications
(115 citation statements)
references
References 25 publications
3
111
0
1
Order By: Relevance
“…A major limitation of the procedure is that it is technically feasible only in patients with extrahepatic biliary ductal dilation (choledochoduodenostomy) in whom the stent can be deployed free‐hand or over a previously placed guidewire. Three studies have examined the role of LAMS in biliary obstruction and reported a technical success rate that was approximately 90% or higher and a clinical success greater than 90%; however, the rates of adverse events were 3.8%, 11.5% and 36.8%, respectively . Although one patient experienced fatal bleeding, other adverse events included food impaction, spontaneous migration and kinking.…”
Section: Current Clinical Applicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…A major limitation of the procedure is that it is technically feasible only in patients with extrahepatic biliary ductal dilation (choledochoduodenostomy) in whom the stent can be deployed free‐hand or over a previously placed guidewire. Three studies have examined the role of LAMS in biliary obstruction and reported a technical success rate that was approximately 90% or higher and a clinical success greater than 90%; however, the rates of adverse events were 3.8%, 11.5% and 36.8%, respectively . Although one patient experienced fatal bleeding, other adverse events included food impaction, spontaneous migration and kinking.…”
Section: Current Clinical Applicationsmentioning
confidence: 99%
“…Three studies have examined the role of LAMS in biliary obstruction and reported a technical success rate that was approximately 90% or higher and a clinical success greater than 90%; however, the rates of adverse events were 3.8%, 11.5% and 36.8%, respectively. [12][13][14] Although one patient experienced fatal bleeding, other adverse events included food impaction, spontaneous migration and kinking. It appears that the existing design of LAMS is not conducive to biliary ductal drainage and may require modification to minimize the incidence of adverse events.…”
Section: Biliary Obstructionmentioning
confidence: 99%
“…28 More recently, the use of lumen-apposing metal stents for EUS-CDS has been successfully demonstrated, expanding the toolbox of modalities. 34 Additional experience will streamline and potentially standardize the management of GOBO scenarios.…”
Section: Discussionmentioning
confidence: 99%
“…The hot AXIOS stent (Xlumena, Inc., Mountain View, CA, USA) is a fully covered, 10-mm-diameter delivery system, with 10-mm-long braided stent with bilateral 20-mm-diameter anchor flanges. These novel SEMSs are mainly used for EUS-guided pseudocystic drainage and EUS-guided cholecystogastrostomy [8][9][10]. These SEMSs also seem useful for EUS-CDS, although clinical trials are needed to confirm their utility.…”
Section: Technical Tipsmentioning
confidence: 99%